Skip to main content
. 2016 Jan 26;4:e1619. doi: 10.7717/peerj.1619

Table 2. Hemodynamic data.

Results are presented as medians and ranges.

Control Isoflurane
T15 T30 Control T15 vs T30 (p-value) T15 T30 Isoflurane T15 vs T30 (p-value)
CI (l min−1 m−2) 2.9 (2.3–3.6) 2.7 (2.1–3.2) 0.11 2.7 (1.6–5.7) 2.6 (1.9–5.8) 0.28
HR (min−1) 89 (53–106) 90 (56–106) 0.65 99 (76–112) 88 (74–100) 0.15
MAP (mmHg) 65 (47–80) 66 (56–84) 0.06 69 (59–85) 57 (48–59) 0.005
MDAP (mmHg) 57 (45–64) 60 (43–71) 0.06 62 (53–79) 50 (45–57) 0.005
DDT (ms) 447 (257–1215) 489 (366–1070) 0.60 721 (240–919) 567 (339–937) 0.33
CVP (mmHg) 9 (7–16) 9 (7–16) 1.0 10 (7–12) 10 (7–13) 0.82
CSP (mmHg) 14 (8–18) 13 (7–18) 0.39 10 (5–20) 10 (6–19) 0.44
SVRI (dyn sec cm−5 m2) 1555 (809–2454) 1716 (1355–2193) 0.31 1730 (850–2969) 1364 (699–1965) 0.04
GEDI (ml m−2) 642 (541–895) 652 (594–883) 0.78 642 (457–834) 617 (479–802) 0.92
EVLWI (ml m−2) 6.8 (5.7–10.0) 6.3 (5.0–8.7) 0.62 7.4 (4.0–10.7) 7.0 (4.3–10.0) 0.16
LVEDP (mmHg) 16 (8–33) 15 (8–30) 0.09 11 (8–37) 13 (9–22) 0.80
SVV (%) 11 (6–17) 12 (5–18) 0.64 12 (5–19) 14 (8–16) 0.43
dp/dtmax (mmHg s−1) 766 (507–1063) 763 (500–887) 0.65 748 (510–1350) 651 (340–1143) 0.02
CFI (min−1) 4.2 (3.5–5.0) 3.7 (2.8–5.0) 0.05 4.6 (2.5–8.1) 3.9 (3.1–7.4) 0.16
COP (mmHg) 39 (23–48) 42 (28–44) 0.25 35 (26–59) 34 (27–42) 0.11
FLOW (ml/min) 26 (10–38) 22 (9–53) 0.72 29 (7–68) 23 (11–50) 0.24
Slope (B1) 1.36 (0.48–2.71) 1.29 (0.46–2.10) 0.49 0.94 (0.50–4.82) 2.03 (0.56–4.41) 0.02
CVR from Slope 1/B1 0.74 (0.37–2.10) 0.78 (0.48–2.17) 0.49 1.06 (0.21–2.02) 0.51 (0.23–1.79) 0.007
CVR from CSP 1.73 (1.21–3.92) 1.83 (0.94–5.51) 0.69 1.80 (0.78–8.83) 1.35 (0.81–3.35) 0.30
CVR from LVEDP 1.66 (0.81–4.05) 1.86 (0.61–5.64) 0.49 1.68 (0.79–5.38) 1.77 (0.73–3.13) 0.06
CVR from COP 0.74 (0.37–2.07) 0.78 (0.46–2.13) 0.44 1.06 (0.21–2.02) 0.51 (0.23–1.79) 0.006